Catalyst system for producing aromatic carbonates
    11.
    发明授权
    Catalyst system for producing aromatic carbonates 失效
    用于生产芳族碳酸酯的催化剂体系

    公开(公告)号:US06355597B1

    公开(公告)日:2002-03-12

    申请号:US09559855

    申请日:2000-04-27

    IPC分类号: B01J2316

    CPC分类号: C07C68/005 C07C69/96

    摘要: A catalyst system for economically producing aromatic carbonates from aromatic hydroxy compounds. In one embodiment, the present invention provides a carbonylation catalyst system that includes a catalytic amount of an inorganic co-catalyst containing bismuth. In various alternative embodiments, the carbonylation catalyst system can include an effective amount of a palladium source and an effective amount of a halide composition. Further alternative embodiments can include catalytic amounts of various inorganic co-catalyst combinations.

    摘要翻译: 用于从芳族羟基化合物经济地生产芳族碳酸酯的催化剂体系。 在一个实施方案中,本发明提供了包含催化量的含有铋的无机助催化剂的羰基化催化剂体系。 在各种替代实施方案中,羰基化催化剂体系可以包括有效量的钯源和有效量的卤化物组合物。 另外的替代实施方案可以包括催化量的各种无机助催化剂组合。

    Method for making aromatic carbonates
    13.
    发明授权
    Method for making aromatic carbonates 失效
    制备芳香族碳酸酯的方法

    公开(公告)号:US06191299B1

    公开(公告)日:2001-02-20

    申请号:US09224162

    申请日:1998-12-31

    IPC分类号: C07C6800

    CPC分类号: C07C68/005 C07C69/96

    摘要: An improved method for producing an aromatic carbonate by reacting an aromatic hydroxy compound, carbon monoxide and oxygen in the presence of a catalyst system comprising at least one of palladium or a palladium compound; at least one lead compound; at least one halide source; and at least one desiccant, wherein the ratio of equivalents of lead co-catalyst relative to equivalents of palladium catalyst is optimized to increase reaction rate, as well as to allow production of aromatic carbonate in an economically feasible continuous process.

    摘要翻译: 一种通过使芳族羟基化合物,一氧化碳和氧在包含钯或钯化合物中的至少一种的催化剂体系的存在下反应制备芳族碳酸酯的改进方法; 至少一种铅化合物; 至少一个卤素源; 和至少一种干燥剂,其中铅助催化剂的当量相对于钯催化剂的当量的比率被优化以提高反应速率,以及允许在经济上可行的连续方法中生产芳族碳酸酯。

    Fluoroalkyl tetrabenazine carbinol compounds as imaging agents and probes
    15.
    发明授权
    Fluoroalkyl tetrabenazine carbinol compounds as imaging agents and probes 失效
    氟烷基四苯并嗪甲醇化合物作为成像剂和探针

    公开(公告)号:US08013161B1

    公开(公告)日:2011-09-06

    申请号:US11952325

    申请日:2007-12-07

    IPC分类号: C07D455/06

    摘要: The present invention provides novel fluoroalkyl tetrabenazine carbinol compounds having structure I wherein R1 is a C1-C10 fluorinated aliphatic radical; R2 is a C1-C10 aliphatic radical; R3 is hydrogen or a C1-C10 aliphatic radical; R4 is hydrogen or a C1-C10 aliphatic radical; and R5 is hydrogen, a C1-C10 aliphatic radical, a C2-C10 cycloaliphatic radical, or a C2-C20 aromatic radical. In a particular embodiment, —OR5 is an ester moiety. The fluoroalkyl tetrabenazine carbinol compounds are provided in both racemic and enantiomerically enriched forms and may comprise either or both of fluorine-18 and fluorine 19. The fluoroalkyl tetrabenazine carbinol compounds are shown to possess high affinity for VMAT-2, a biomarker implicated in human diabetes. The fluoroalkyl tetrabenazine carbinol compounds comprising a fluorine-18 group are useful as PET imaging agents targeting the VMAT-2 biomarker. The non-radiolabled fluoroalkyl tetrabenazine carbinol compounds are useful as probes for the discovery of PET imaging agents.

    摘要翻译: 本发明提供具有结构I的新型氟代烷基四苯并嗪甲醇化合物,其中R 1是C 1 -C 10氟化脂族基; R2是C1-C10脂族基团; R3是氢或C1-C10脂族基; R4是氢或C1-C10脂族基; 并且R 5是氢,C 1 -C 10脂族基,C 2 -C 10脂环族基或C 2 -C 20芳族基。 在一个具体实施方案中,-OR 5是酯部分。 氟烷基四苯并嗪甲醇化合物以外消旋和对映异构体富集的形式提供,并且可以包含氟-18和氟19中的一种或两种。氟烷基丁苯那嗪甲醇化合物显示对VMAT-2具有高亲和力,VMAT-2是涉及人类糖尿病的生物标记 。 包含氟-18基团的氟代烷基四苯并嗪甲醇化合物可用作靶向VMAT-2生物标志物的PET显像剂。 非放射性氟烷基丁苯那嗪甲醇化合物可用作发现PET成像剂的探针。

    Intermediates for alpha-fluoroalkyl tetrabenazine and dihydrotetrabenazine imaging agents and probes
    16.
    发明授权
    Intermediates for alpha-fluoroalkyl tetrabenazine and dihydrotetrabenazine imaging agents and probes 有权
    α-氟烷基丁苯那嗪和二氢丁苯那嗪成像剂和探针的中间体

    公开(公告)号:US07910738B2

    公开(公告)日:2011-03-22

    申请号:US11947275

    申请日:2007-11-29

    IPC分类号: C07D455/06

    CPC分类号: C07D455/06 C07D491/20

    摘要: The present invention provides novel fluorophilic compounds having structure VII wherein Q is a carbonyl group, a protected carbonyl group, a hydroxy methine group, or a protected hydroxy methine group; R1 is a C1-C20 aliphatic, C2-C20 cycloaliphatic, or C2-C20 aromatic radical comprising at least one functional group susceptible to reaction with nucleophilic fluoride ion or an electrophilic fluorinating agent; R2 is hydrogen or a C1-C10 aliphatic radical; and R3 is hydrogen or a C1-C10 aliphatic radical. The fluorophilic compounds are provided in both racemic and enantiomerically enriched forms and are useful as intermediates in the preparation of novel PET imaging agents and probes useful in the discovery and performance assessment of PET imaging agents. The fluorophilic compounds are particularly useful in the preparation of PET imaging agents and probes having a high affinity for VMAT-2, a biomarker implicated in human diabetes and other illnesses such as Parkinson's disease.

    摘要翻译: 本发明提供具有结构VII的新型氟化合物,其中Q为羰基,被保护的羰基,羟基次甲基或被保护的羟基次甲基; R1是包含至少一个与亲核氟离子或亲电氟化剂反应敏感的官能团的C 1 -C 20脂族,C 2 -C 20脂环族或C 2 -C 20芳族基团; R2是氢或C1-C10脂族基; 并且R 3是氢或C 1 -C 10脂族基。 亲氟化合物以外消旋和对映体富集的形式提供,并且可用作制备用于PET成像剂的发现和性能评估的新型PET成像剂和探针的中间体。 亲氟化合物特别可用于制备对VMAT-2具有高亲和力的PET成像剂和探针,所述VMAT-2是涉及人类糖尿病和其它疾病如帕金森病的生物标志物。

    Alpha-fluoroalkyl tetrabenazine and dihydrotetrabenazine imaging agents and probes
    17.
    发明授权
    Alpha-fluoroalkyl tetrabenazine and dihydrotetrabenazine imaging agents and probes 有权
    α-氟烷基丁苯那嗪和二氢丁苯那嗪成像剂和探针

    公开(公告)号:US07902364B2

    公开(公告)日:2011-03-08

    申请号:US11947215

    申请日:2007-11-29

    IPC分类号: C07D455/06

    摘要: The present invention provides novel alpha-fluoroalkyl compounds having structure I and the corresponding dihydrotetrabenazine compounds IV wherein R1 is a C1-C10 fluorinated aliphatic radical; R2 is hydrogen or a C1-C10 aliphatic radical; and R3 is hydrogen or a C1-C10 aliphatic radical. The alpha-fluoroalkyl compounds are provided in both racemic and enantiomerically enriched forms and may comprise either or both of fluorine-18 and fluorine 19. The alpha-fluoroalkyl compounds are shown to possess high affinity for VMAT-2, a biomarker implicated in human diabetes. The alpha-fluoroalkyl compounds comprising a fluorine-18 group are useful as PET imaging agents targeting the VMAT-2 biomarker. The non-radiolabled alpha-fluoroalkyl compounds are useful as probes for the discovery of PET imaging agents.

    摘要翻译: 本发明提供具有结构I和相应的二氢丁苯那嗪化合物IV的新的α-氟烷基化合物,其中R 1是C 1 -C 10氟化脂族基; R2是氢或C1-C10脂族基; 并且R 3是氢或C 1 -C 10脂族基。 α-氟烷基化合物以外消旋和对映异构体富集的形式提供,并且可以包含氟-18和氟19中的任一种或两者。所述α-氟代烷基化合物显示对VMAT-2具有高亲和力,VMAT-2是涉及人类糖尿病的生物标记 。 包含氟-18基团的α-氟烷基化合物可用作靶向VMAT-2生物标志物的PET成像剂。 非放射性α-氟烷基化合物可用作发现PET成像剂的探针。

    ALPHA-FLUOROALKYL TETRABENAZINE AND DIHYDROTETRABENAZINE IMAGING AGENTS AND PROBES
    18.
    发明申请
    ALPHA-FLUOROALKYL TETRABENAZINE AND DIHYDROTETRABENAZINE IMAGING AGENTS AND PROBES 有权
    阿尔法 - 氟代苄基四氢萘酮和二氢苯并咪唑成像剂和探针

    公开(公告)号:US20090142265A1

    公开(公告)日:2009-06-04

    申请号:US11947215

    申请日:2007-11-29

    IPC分类号: A61K51/04 C07D471/04

    摘要: The present invention provides novel alpha-fluoroalkyl compounds having structure I and the corresponding dihydrotetrabenazine compounds IV wherein R1 is a C1-C10 fluorinated aliphatic radical; R2 is hydrogen or a C1-C10 aliphatic radical; and R3 is hydrogen or a C1-C10 aliphatic radical. The alpha-fluoroalkyl compounds are provided in both racemic and enantiomerically enriched forms and may comprise either or both of fluorine-18 and fluorine 19. The alpha-fluoroalkyl compounds are shown to possess high affinity for VMAT-2, a biomarker implicated in human diabetes. The alpha-fluoroalkyl compounds comprising a fluorine-18 group are useful as PET imaging agents targeting the VMAT-2 biomarker. The non-radiolabled alpha-fluoroalkyl compounds are useful as probes for the discovery of PET imaging agents.

    摘要翻译: 本发明提供具有结构I和相应的二氢丁苯那嗪化合物IV的新的α-氟烷基化合物,其中R 1是C 1 -C 10氟化脂族基; R2是氢或C1-C10脂族基; 并且R 3是氢或C 1 -C 10脂族基。 α-氟烷基化合物以外消旋和对映异构体富集的形式提供,并且可以包含氟-18和氟19中的任一种或两者。所述α-氟烷基化合物显示对VMAT-2具有高亲和力,VMAT-2是涉及人类糖尿病的生物标记 。 包含氟-18基团的α-氟烷基化合物可用作靶向VMAT-2生物标志物的PET成像剂。 非放射性α-氟烷基化合物可用作发现PET成像剂的探针。